US Stock MarketDetailed Quotes
HUMA Humacyte
- 4.520
- +0.120+2.73%
Close Nov 29 13:00 ET
- 4.470
- -0.050-1.11%
Post 17:01 ET
581.58MMarket Cap-3373P/E (TTM)
4.540High4.410Low1.07MVolume4.440Open4.400Pre Close4.82MTurnover1.12%Turnover RatioLossP/E (Static)128.67MShares9.97052wk High-9.13P/B432.17MFloat Cap2.45152wk Low--Dividend TTM95.61MShs Float17.450Historical High--Div YieldTTM2.96%Amplitude1.960Historical Low4.481Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Humacyte Stock Forum
🏄🏼♂️🏄🏼♂️🏄🏼♂️
🥱🥱🥱😴😴😴
🚀🚀🚀 USD 6 Stsge 3 results going to be announced... parking.
I see more Quantum play this week.
$Quantum (QMCO.US)$ AWS launched QuantumEmbark. Up after hours. Small float. 0 shares LTB.
$Arqit Quantum (ARQQ.US)$ AWS launched Quantum Embark.Increased market cap which translates to stock increasing in stock value and increased confidence in the stock. Low floa...
Benzinga· 3 mins ago
Humacyte to Present Efficacy and Safety Results from V007 Phase 3 AV Access Clinical Trial at the 51st Annual Symposium on Vascular and Endovascular Issues, Techniques and Horizons (VEITH)
Humacyte (Nasdaq: HUMA) announced it will present Phase 3 results comparing the efficacy and safety of its acellular tissue engineered vessel (ATEV™) with autologous AV fistulas in end-stage renal disease patients. The presentation will be delivered by Dr. Charles Keith Ozaki at the 51s...
– sdATEVs maintained sustained patency throughout the six-month study –
– sdATEV was observed to recellularize with host cells and remodel to effectively re...
what happened? the earnings suck but now the stock is rising
No comment yet